The Week

Bank of America (BAC) closed the week at $62.69, up 0.02% over the four sessions. The S&P 500 fell 0.8%, so the stock outperformed the benchmark by roughly 0.82 percentage points. Trading was choppy rather than directional. Tuesday opened lower and settled at $62.39; Wednesday dipped to $61.425 intraday before recovering to $62.67; Thursday eased to $62.56; Friday gapped up, touched $63.83, then slipped back to $62.69. The week’s range was $61.425 to $63.83, an amplitude of 3.85%. On the 60-day view, the close sits in the upper part of a $56.03 to $65.225 band, with the 20-day moving average at $62.619 just below spot.

Key Events

The week brought few direct operational updates from BAC. The most visible corporate activity came from its securities unit, which filed a string of 424B2 documents; 20 were material filings inside the week, with 12 clustered late Friday night into early Saturday, mostly structured-product supplements tied to financing rather than new business lines. The bank also adjusted several equity stakes. On 11 September it disclosed cutting its Gerdau position below 5%, to 4.12%, and lifting its Delivery Hero voting-rights stake from 4.38% to 5.13%. A day later it trimmed Abivax to 4.96%. These crosses above and below the 5% threshold are typically mechanical, driven by net share sales or index moves. On the macro side, BofA pointed to record diesel prices as a real-economy pressure point and flagged potential volatility ahead, naming low-beta ETFs as a defensive option. Bloomberg also reported that Goldman Sachs and BofA are competing to manage millions of dollars from Anthropic employees’ IPO.

Analyst Ratings

Among 24 institutions covering BAC, 15 rate it buy, 5 rate it outperform, and 4 rate it hold; none rate it underperform or sell. Combined buy and outperform counts total 20, about 83% of coverage. The consensus rating is buy, with a consensus target of $69, roughly 10.07% above the $62.69 close. The target range is wide: $62 at the low end sits almost exactly at spot, while the high of $79 implies about 26% upside, so dispersion around the upside case is meaningful. Within the diversified banks industry, BAC’s rating ranks third. Rating updates are current readings rather than week-on-week changes.

The Week Ahead

Next week starts with a run of macro prints. On 15 September the New York Fed manufacturing index lands, with a prior of 20.6 and a forecast of 14.75. On 16 September retail data dominates: headline retail sales carry a prior of -0.6 and a forecast of 0.9, retail sales excluding autos a prior of -0.3 and forecast of 0.6, and the control group a prior of -0.4 and forecast of 0.4. Import prices, the NAHB housing index and EIA crude inventories also hit the same day. For banks, retail sales and import prices will feed the rate-expectations conversation. The next company-specific event is BAC’s fiscal third-quarter report on 14 October before market open, where consensus estimates sit at $312 billion in revenue and EPS of $1.1862.

In Short

BAC barely moved this week while the broader market fell, and the rating skew remains clearly positive: 20 of 24 institutions rate the stock buy or outperform, with a consensus target about 10% above spot. Yet the gap between the highest and lowest targets, roughly 26%, shows the upside case is not settled. Valuation is ordinary for a large bank, at 13.65x earnings and 1.59x book. The latest session’s fund flow shows large, medium and small-lot money all net sellers, suggesting limited near-term absorption. The picture is a stock holding above $62, with a positive rating backdrop but cautious flow; the next catalysts are mid-September retail data and the October earnings print.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.